Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01172353 |
|
Recruitment Status :
Completed
First Posted : July 29, 2010
Results First Posted : February 19, 2014
Last Update Posted : February 19, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Renal Failure | Drug: sodium bicarbonate Drug: saline | Phase 3 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 301 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | Hydration With Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy: A Multicenter Clinical Trial |
| Study Start Date : | July 2004 |
| Actual Primary Completion Date : | January 2008 |
| Actual Study Completion Date : | February 2008 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: sodium bicarbonate
hydration with sodium bicarbonate
|
Drug: sodium bicarbonate
hydration with sodium bicarbonate 1ml/Kg/h for 6 hours |
|
Active Comparator: saline
hydration with saline 1ml/Kg/h for 6 hours
|
Drug: saline
hydration with saline 1ml/Kg/h for 6 hours |
- Contrast-induced Nephropathy [ Time Frame: 48 hours ]rise in serum creatinine >0,5mg/dl
- Dialysis During Hospitalization [ Time Frame: During hospitalization ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- serum creatinine > 1.1 mg/dL
- glomerular filtration rate (GFR) < 50 mL/min
Exclusion Criteria:
- age < 18 years
- use of radiographic contrast media during the last 21 days
- history of dialysis
- cardiac insufficiency class III-IV
- emergency procedures
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01172353
| Brazil | |
| São Lucas Hospital - PUCRS University | |
| Porto Alegre, RS, Brazil, 90610-000 | |
| Responsible Party: | Vitor Osorio Gomes, MD, PhD, Hospital Sao Lucas da PUCRS |
| ClinicalTrials.gov Identifier: | NCT01172353 |
| Other Study ID Numbers: |
HSaoLucas |
| First Posted: | July 29, 2010 Key Record Dates |
| Results First Posted: | February 19, 2014 |
| Last Update Posted: | February 19, 2014 |
| Last Verified: | January 2014 |
|
contras-induced nephropathy |
|
Kidney Diseases Urologic Diseases |

